GlassScriptPhysician profile
Ben M Chue
NPI 1881651313
$20,999.55
in general payments reported to CMS, 2019-2025
84 companies · $407 in 2025
The $407 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,501 · 2020: $2,218 · 2021: $2,345 · 2022: $3,210 · 2023: $4,212 · 2024: $4,107 · 2025: $407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,516 · Education: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,515.78 |
| Education | $209.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,519.56 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $1,517.97 | 2019-2024 | Calquence, Enhertu, Onglyza |
| Janssen Biotech, INC. | $1,486.04 | 2019-2025 | Darzalex, Imbruvica, Tecvayli |
| E.R. Squibb & Sons, L.L.C. | $1,042.30 | 2019-2023 | Opdivo, Reblozyl |
| Seagen INC. | $909.14 | 2019-2023 | Tukysa, Adcetris, Padcev |
| Lilly USA, LLC | $862.12 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Amgen INC. | $732.52 | 2019-2024 | Kyprolis, Blincyto, Lumakras |
| Glaxosmithkline, LLC. | $706.40 | 2020-2025 | Jemperli, Zejula, Ojjaara |
| Taiho Oncology, INC. | $564.53 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $503.61 | 2019-2025 | Alunbrig, Ninlaro, Fruzaqla |
| Eisai INC. | $499.76 | 2020-2024 | |
| Pharmacyclics LLC, An Abbvie Company | $455.18 | 2019-2022 | |
| Array Biopharma INC | $435.53 | 2020-2024 | Mektovi, Lorbrena, Braftovi |
| Merck Sharp & Dohme LLC | $428.01 | 2019-2023 | Lynparza, Keytruda, Welireg |
| Novartis Pharmaceuticals Corporation | $421.96 | 2019-2024 |
Show all 84 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $382.64 | 2019-2024 | Trodelvy |
| Astellas Pharma US INC | $381.85 | 2019-2025 | Cresemba, Padcev, Xospata |
| Emd Serono, INC. | $375.38 | 2020-2024 | Bavencio |
| Tersera Therapeutics LLC | $371.78 | 2022-2024 | Quzyttir, Zoladex |
| Janssen Pharmaceuticals, INC | $360.78 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $342.69 | 2019-2024 | Gilotrif |
| Genentech USA, INC. | $341.45 | 2019-2024 | Lunsumio, Polivy |
| Organon LLC | $339.12 | 2022-2024 | Ontruzant |
| Celgene Corporation | $328.47 | 2019-2024 | Reblozyl |
| Genmab U.S., INC. | $327.18 | 2023-2025 | Epkinly |
| Daiichi Sankyo INC. | $315.45 | 2021-2025 | Enhertu, Injectafer |
| Genzyme Corporation | $249.66 | 2019-2023 | |
| Morphosys, US INC. | $232.62 | 2021-2023 | Monjuvi |
| Incyte Corporation | $230.91 | 2019-2024 | Jakafi, Monjuvi |
| Octapharma USA, INC. | $228.91 | 2019-2023 | Octagam Immune Globulin (Human) |
| Macrogenics, INC. | $221.55 | 2022-2023 | |
| Tesaro, INC. | $197.53 | 2019 | |
| Coherus Oncology, INC. | $194.55 | 2022-2024 | |
| Blueprint Medicines Corporation | $170.49 | 2020-2024 | Ayvakit |
| G1 Therapeutics, INC. | $166.15 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $161.77 | 2019-2024 | |
| Aveo Pharmaceuticals, INC. | $156.65 | 2021-2024 | Fotivda |
| Kite Pharma, INC. | $144.67 | 2020-2023 | Yescarta |
| Foundation Medicine, INC. | $144.50 | 2023 | Foundationone Cdx |
| Sobi, INC | $143.45 | 2023-2024 | |
| Aimmune Therapeutics, INC. | $134.52 | 2024-2025 | Zenpep |
| Deciphera Pharmaceuticals INC. | $125.41 | 2021-2025 | Qinlock, Romvimza |
| Mylan Institutional INC. | $119.10 | 2019-2020 | |
| Helsinn Therapeutics (U.S.), INC. | $116.16 | 2019 | |
| Exelixis INC. | $109.35 | 2020-2023 | Cabometyx |
| Abbvie INC. | $108.62 | 2020-2023 | Venclexta |
| Tempus Ai, INC | $99.73 | 2024 | |
| Ipsen Biopharmaceuticals, INC | $91.49 | 2019-2024 | Onivyde |
| Rigel Pharmaceuticals, INC. | $87.87 | 2019-2024 | Tavalisse, Rezlidhia |
| Regeneron Healthcare Solutions, INC. | $87.29 | 2022-2024 | Libtayo |
| Stemline Therapeutics INC. | $86.80 | 2023-2025 | Orserdu |
| Acrotech Biopharma INC. | $81.41 | 2023-2025 | Beleodaq |
| Clovis Oncology, INC. | $74.87 | 2019-2020 | |
| Fortovia Therapeutics, INC. | $67.97 | 2019 | |
| Jazz Pharmaceuticals INC. | $65.02 | 2021 | |
| Mirati Therapeutics, INC. | $60.96 | 2023 | Krazati |
| Heron Therapeutics, INC. | $58.87 | 2019-2022 | |
| Aadi Bioscience, INC. | $53.31 | 2023 | Fyarro |
| Cti Biopharma Corp. | $47.54 | 2022-2023 | Vonjo |
| Epizyme, INC. | $46.21 | 2023 | Tazverik |
| Acceleron Pharma, INC. | $45.05 | 2021 | |
| Pharmacosmos Therapeutics INC. | $44.80 | 2023-2024 | Monoferric |
| Dendreon Pharmaceuticals LLC | $44.73 | 2019-2025 | Provenge |
| Sun Pharmaceutical Industries INC. | $44.39 | 2023-2024 | Odomzo, Yonsa |
| Puma Biotechnology, INC. | $44.12 | 2022-2025 | |
| Dova Pharmaceuticals | $37.58 | 2019-2021 | |
| Accord Healthcare, INC. | $37.32 | 2024 | |
| Apellis Pharmaceuticals, INC. | $32.12 | 2023 | Empaveli |
| Shield Therapeutics INC | $30.96 | 2023 | Accrufer |
| Beigene USA, INC. | $30.09 | 2022 | |
| Fresenius Kabi USA, LLC | $29.61 | 2023 | Stimufend |
| Amneal Pharmaceuticals LLC | $26.04 | 2022 | |
| Syndax Pharmaceuticals, INC. | $24.83 | 2025 | |
| Alexion Pharmaceuticals, INC. | $23.37 | 2019 | |
| Adma Biomanufacturing LLC | $22.75 | 2022 | |
| Karyopharm Therapeutics INC. | $21.71 | 2020 | |
| Agios Pharmaceuticals, INC. | $20.30 | 2024 | Pyrukynd |
| Myovant Sciences INC. | $19.91 | 2021 | |
| Myriad Genetic Laboratories, INC. | $19.82 | 2024 | Precisetumor |
| Adaptive Biotechnologies Corporation | $17.75 | 2024 | Clonoseq |
| Adc Therapeutics America, INC. | $17.42 | 2022 | |
| Sirtex Medical INC | $17.00 | 2020 | |
| Pharming Healthcare, INC. | $16.22 | 2023 | Ruconest |
| Roche Diagnostics Corporation | $14.33 | 2019 |
Drugs and devices associated with these payments
Jemperli $375Lonsurf $360Inqovi $360Enhertu $331Epkinly $327Quzyttir $305Lorbrena $302Zejula $297Mektovi $284Braftovi $260Jaypirca $234Tukysa $215Ontruzant $213Calquence $199Xalkori $196Verzenio $189Udenyca $176Kisqali $158Padcev $158Lynparza $153Ibrance $145Alunbrig $139Adcetris $138Xtandi $137Jakafi $129Opdivo $120Retevmo $114Gilotrif $114Bavencio $113Doptelet $105Inlyta $105Cresemba $102Keytruda $98.12Lenvima $95.88Qinlock $92.06Polivy $90.68Lunsumio $90.68Onglyza $88.72Orserdu $86.80Faslodex $84.76Zenpep $84.64Beleodaq $81.41Reblozyl $81.24Darzalex $74.08Margenza $70.32Libtayo $66.39Ninlaro $65.78Stivarga $65.77Vitrakvi $65.77Tavalisse $63.54Rezlidhia $63.54Xospata $63.38Vonjo $61.87Elrexfio $61.22Krazati $60.96Talzenna $59.23Ojjaara $59.13Paxlovid $57.99Comirnaty $53.96Fyarro $53.31Pluvicto $52.72Imbruvica $52.47Ayvakit $51.81Vowst $49.88Kyprolis $48.87Zoladex $47.08Tazverik $46.21Monoferric $44.80Odomzo $44.39Yonsa $44.39Imfinzi $44.05Monjuvi $43.93Fotivda $37.74Camcevi $37.32Injectafer $33.31Venclexta $32.65Empaveli $32.12Piqray $32.04Foundationone Cdx $31.94Accrufer $30.96Nurtec Odt $30.71Eliquis $30.71Elitek $30.01Sarclisa $30.01Stimufend $29.61Fruzaqla $29.30Blincyto $29.15Lumakras $27.92Romvimza $27.76Welireg $26.33Vyloy $26.15Fabhalta $25.10Onivyde $25.09Tecvayli $24.79Nerlynx $23.62Yescarta $23.47Octagam Immune Globulin (Human) $22.82Nplate $22.20Xgeva $22.20Vectibix $22.20
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ben Chue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.